• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·002014.SZ
Share

Huangshan Novel Co.,Ltd Stocks

CN¥ 11.39Last Updated 12.10.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

CN¥ 1.04B

CN¥ 11.39
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1992 and headquartered in Huangshan, China, Huangshan Novel Co., Ltd. specializes in the manufacturing and supply of packaging materials, primarily serving the Chinese market. The company's diverse product portfolio encompasses various films, such as color-printed plastic, flexible laminates, vacuum-metallized, and multi-functional types. It also provides medical packaging, breathable and protective membranes, and injection molding compounds. These materials are widely applied across numerous industries, including food and beverage, daily consumer products, pharmaceuticals, agricultural chemicals, electronics, and building materials. Beyond its domestic operations, the firm actively exports its goods to international destinations, such as Europe, the United States, Mexico, Japan, the Middle East, and other regions in Asia.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.10.2026 18:58

Oppenheimer recommends buying Fastly stock ahead of the earnings report and the release of the iconic game GTA

12.10.2026 18:03

Shares of Nebius' competitor surged following news of a contract with Anthropic

12.10.2026 17:57

China's CXMT has unsettled investors in Micron and Samsung, causing their stock prices to fall. What's going on?

12.10.2026 16:53

Jennifer Garner's company could see its stock price rise by 50%: Freedom has identified unaccounted-for growth drivers

12.10.2026 16:43

"The bar is being raised for any IPO": What signal does the cancellation of Firmus's listing send to the market?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026